A non-profit organization dedicated to harnessing the immune system's power to control and potentially cure all types of cancer through research, awareness, and immunotherapy development.

Cancer Research Institute

Founded in 1953, the New York City-based Cancer Research Institute is a nonprofit organization dedicated to extending the lives of cancer patients and reducing cancer-related deaths by fueling the development of smarter, more effective treatments that mobilize our body’s natural immune defenses against all types of cancer.

To accomplish this goal, the Cancer Research Institute supports the most critical research, invests in the development of promising new treatments, and unites the efforts of the field’s leaders worldwide. Through this work, Cancer Research Institute is transforming cancer therapy, enabling patients to live longer, healthier lives free from the fear of cancer. 

For more information visit www.cancerresearch.org.

Cancer Research Institute (CRI)

Did you know? The Cancer Research Institute is ranked among the top 5% of all U.S. rated charities. Give with confidence, and make an impact by donating today to fund lifesaving cancer immunotherapy research: https://bit.ly/44of8ML #CancerResearch #Immunotherapy #CharityRatings #GiveWithConfidence

"CICON is the only meeting I can think of that brings together so many experts in the field to network and collaborate," says Dr. Elizabeth M. Jaffee, Meeting Co-Chair, and Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medicine. Register to attend #CICON24 by July 15 to receive early-bird pricing! Sign up today, and save: https://bit.ly/3wkc5sQ #CancerResearch #CICON #CancerResearcher #Immunotherapy

Today is Glioblastoma Awareness Day. Understand why GBM is such a deadly type of cancer, hear a patient's story of survival, and discover how CRI-funded researchers are improving patient outcomes, in our new blog post. "Every patient with glioblastoma [whom] I have ever had the privilege of treating is full of resolve, hope, fortitude, and courage," shares CRI Lloyd J. Old STAR Dr. Gavin Dunn of Massachusetts General Hospital. "We owe it to our patients to study their brain cancers and improve their lives." Read more: https://bit.ly/3WaiNeb #GlioblastomaAwarenessDay #GBM #Glioblastoma #CancerResearch #Immunotherapy

“Without a shadow of a doubt, immunotherapy saved my life,” expresses Jeff, a melanoma survivor. Discover the transformative impact of immunotherapy, and gain insight into a patient's perspective, through Jeff's first-hand account of his immunotherapy journey: https://bit.ly/4cQ7Gh9 #CancerResearch #Immunotherapy #CRISummit #Melanoma

Published in Springer Nature Group's Nature Medicine, findings from a small clinical trial suggest that a new cellular immunotherapy approach could be effective in treating metastatic solid tumors. Researchers from The National Institutes of Health, including 2020 American Association for Cancer Research- CRI Lloyd J. Old Award recipient Dr. Steven Rosenberg, genetically engineered lymphocytes from each patient to produce receptors that recognize and attack their cancer cells. The personalized immunotherapy shrank tumors in some patients, and was able to halt tumor regrowth for up to seven months. “It's just the very beginning of converting normal lymphocytes into cells capable of treating the common solid cancers,” says Dr. Rosenberg. “What this study shows is that it's possible. Once you know it’s possible, you work to improve it.” Read more: https://bit.ly/3xUJoUs #ColorectalCancer #Immunotherapy #CancerResearch

Register today to discover Pancreatic Cancer Demystified: Expert Insights and Breakthroughs with Robert H. Vonderheide, MD, DPhil!
 
Pancreatic cancer, often termed “the silent killer,” is a relentless and merciless adversary. Ranking as the world’s most lethal form of cancer, it is currently the fourth leading cause of cancer-related deaths in United States.  

Why is pancreatic cancer so difficult to diagnose? What treatment options are available against such a deadly foe? Join us on June 26 for an exclusive, live webinar featuring renowned cancer immunologist, CRI Scientific Advisory Council member, and Clinical Accelerator Investigator, Robert H. Vonderheide, MD, DPhil, from the Abramson Cancer Center of the University of Pennsylvania.

Dr. Vonderheide will delve into these pressing questions and provide a deeper dive into the latest advances in immunotherapy for pancreatic cancer patients. This is a unique opportunity to gain invaluable insights from one of the leading experts in the field. #CancerResearch #PancreaticCancer

HSTS

Apache

CrUX Dataset

Person Schema

CrUX Top 50m

Gravatar Profiles

Offer Schema

Elementor

Java EE

Express

Chief Communications Officer

Brian Brewer

Chief Development Officer

Brian Leidy

Chief Information Officer

Rupinder Kaur

Director of Development

Abby Smith

Business Management

Ajit Muley

Associate Director, Marketing

Alice Northover

Associate Director, Scientific Content

Arthur Brodsky

Associate Director, Individual Giving

Christine Bove

Donation Manager

Devi Sharma

Director of Communications

Dustin Etheridge

Drew Pardoll

Gabriel Stricker

Paul Sekhri

Peter Bloom

Trustee

Jill O'Donnell Tormey

Chief Executive Officer & Director of Scientific Affairs

City of New York Companies With Fewer Than 50 Employees (Top 10K)

Greater New York Area Education Companies

New York Companies With Less Than $1M in Revenue (Top 10K)

Greater New York Area Biotechnology Companies

The Cancer Research Institute (CRI) is a nonprofit organization dedicated to harnessing the immune system's power to conquer all cancers.
This important work has led to a promising new class of cancer treatments called cancer immunotherapy. These treatments mobilize, strengthen, and sustain the immune system's natural ability to destroy cancer cells, wherever they are in the body. Learn more about cancer immunotherapy here.


CRI awards research grants and fellowships to support scientists at leading research universities and clinics around the world. Funding decisions are guided by a Scientific Advisory Council composed of renowned immunologists and tumor immunologists, including Nobel Prize winners,  members of the National Academy of Sciences, and members of the Academy of Cancer Immunology.

New York

United States

North America

Fucosylation and immune surveillance in melanoma

Methods for identifying disseminated cancer cells in breast cancer patients

Methods of treating cancer comprising administration of intratumoral dcs in …

Inhibitors of the ire-1/xbp-1 pathway and methods of using thereof

Prodrugs of temozolomide to facilitate delivery into brain tumors

Bob Langer, Cancer Research Institute Back Intraoperative Immunotherapy Pioneer

Canada

Dominican Republic

United Kingdom

Europe

India

Asia

HTML5

Fonts.com

Google Analytics

Adobe Fonts

Vimeo

.NET 4.5

Modernizr

Sumo

Office 365

DigiCert

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 18, 2024 5:08 AM	5964c2b1
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Oct 31, 2024 9:55 AM	da7a0962
crunchbase profile	general	Oct 31, 2024 11:01 AM	685d4117
li profile	general	Jul 18, 2024 5:08 AM	f691ffab
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	2492a46c
peers	general	Jul 18, 2024 5:08 AM	e3c57f10
news basic	general	Jul 18, 2024 5:08 AM	7047fd46
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

CANC

ORG:CANCERRESEARCH

Cancer Research Institute